Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Atasi Poddar
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
ORCID:
0009-0004-1393-669X
Observed ORCID:
0009-0004-1393-669X
OpenAlex ID:
A5113040241
Demographic Diversity of Clinical Trials for Therapeutic Drug Products: A Systematic Review of Recently Published Articles, 2017‐2022
2023
·
Wambui Chege
, Atasi Poddar
, et al.
·
The Journal of Clinical Pharmacology
·
8
PDF
Leveraging Artificial Intelligence in Drug and Biological Product Development: An FDA and Clinical Trial Transformation Initiative Workshop Report
2025
·
Atasi Poddar
, Marsha Samson
, et al.
·
NEJM AI
·
5
Mitigating Limited Data Challenges to Improve Artificial Intelligence Integration in Rare Disease Drug Development
2025
·
Atasi Poddar
, Gabriel K. Innes
, et al.
·
NEJM AI
·
4
Decisions on Non-oncology Breakthrough Therapy Designation Requests in 2017–2019
2023
·
Atasi Poddar
, Miranda Raggio
, et al.
·
Therapeutic Innovation & Regulatory Science
·
3
PDF
Show more works
View as search
Works count:
4
Citation count:
20
H-index:
3
I10-index:
Year
Topic
Type